Tenaya Therapeutics (TNYA) Other Non Operating Income (2020 - 2026)
Tenaya Therapeutics (TNYA) posted quarterly Other Non Operating Income of $25000.0 for Q4 2025, up 525.0% year-over-year from $4000.0 in Q4 2024, and up 733.33% quarter-over-quarter from $3000.0 in Q3 2025.
Tenaya Therapeutics (TNYA) Other Non Operating Income (2020 - 2026) Analysis & Trends
Tenaya Therapeutics' Other Non Operating Income history runs 6 years deep, the most recent figure standing at $25000.0 for Q4 2025.
- In Q4 2025, Other Non Operating Income rose 525.0% year-over-year to $25000.0; the TTM figure through Dec 2025 stood at $51000.0 (down 37.8% YoY), while the FY2025 annual figure was $52000.0, down 36.59% from the prior year.
- Other Non Operating Income for Q4 2025 stood at $25000.0, up from $3000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $82000.0 in Q1 2024, with the low at -$54000.0 in Q4 2021.
- The 5-year median for Other Non Operating Income is $3000.0 (2025), against an average of $8684.2.
- Peak annual rise in Other Non Operating Income reached 1600.0% in 2021, while the deepest fall reached 5300.0% in 2021.
- Tenaya Therapeutics' Other Non Operating Income stood at -$54000.0 in 2021, then soared by 94.44% to -$3000.0 in 2022, then soared by 1466.67% to $41000.0 in 2023, then slumped by 90.24% to $4000.0 in 2024, then jumped by 525.0% to $25000.0 in 2025.
- Business Quant data shows TNYA's Other Non Operating Income at $25000.0 in Q4 2025, $3000.0 in Q3 2025, and -$16000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Tenaya Therapeutics | 151.50 Mn | 151.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2,000.00 |
| Dec 31, 2025 | 25,000.00 |
| Sep 30, 2025 | 3,000.00 |
| Jun 30, 2025 | -16,000.00 |
| Mar 31, 2025 | 39,000.00 |
| Dec 31, 2024 | 4,000.00 |
| Sep 30, 2024 | -3,000.00 |
| Jun 30, 2024 | -1,000.00 |
| Mar 31, 2024 | 82,000.00 |
| Dec 31, 2023 | 41,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | -2,000.00 |
| Mar 31, 2023 | 13,000.00 |
| Dec 31, 2022 | -3,000.00 |
| Sep 30, 2022 | 6,000.00 |
| Mar 31, 2022 | -1,000.00 |
| Dec 31, 2021 | -54,000.00 |
| Sep 30, 2021 | 15,000.00 |
| Jun 30, 2021 | 18,000.00 |
| Mar 31, 2021 | -2,000.00 |